Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection
Long-acting
injectable regimens may simplify therapy for patients with human
immunodeficiency virus type 1 (HIV-1) infection.
|
View article...
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.
Long-acting
injectable regimens may simplify therapy for patients with human
immunodeficiency virus type 1 (HIV-1) infection.
|